A mutation causes a defect in the production of exosomes, which has been shown to drive the progression of Alzheimer's ...

Impurities and instability are challenges for all drugs, but a growing range of technological tools are helping drug developers and manufacturers minimize them.

With CDMOs playing such a prominent role in biomanufacturing, GEN asked several CDMO leaders for their take on the top trends in the industry, the main challenges facing CDMOs today, and the most ...

Next-generation sequencing enhances a biologics manufacturer's ability to detect and identify unknown or unexpected contaminants.

GEN spotlights some of the remarkable women who are breaking barriers, setting standards, and driving innovation in this space.

The method offers a scalable way to scour unculturable bacteria for new drug leads and help illuminate a previously hidden microbial world.